Foslevodopa/Foscarbidopa Overnight Administration Improves Nocturia in Patients with Parkinson's Disease: Evidence from a Real-World Study
{{output}}
Background: Nocturia is considered as one of the commonest nonmotor symptoms in people with Parkinson's disease (PD), highly impacting on quality-of-life and health-related costs. ... ...
